1156O Surufatinib (S) for patients (Pts) with advanced...

Annals of Oncology 2020 / 09 Vol. 31

1156O Surufatinib (S) for patients (Pts) with advanced pancreatic neuroendocrine tumours (SANET-p): A randomized, double-blind, placebo (P)-controlled phase III trial (NCT02589821)

Xu, J., Shen, L., Bai, C., Li, J., Zhou, Z., Yu, X., Li, Z., Li, E., Yuan, X., Chi, Y., Yin, Y., Lou, W., Xu, N., Bai, Y., Zhang, T., Xiu, D., Wang, X., Li, J., Fan, S., Su, W.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.08.1369
Date:
September, 2020
File:
PDF, 152 KB
2020
Conversion to is in progress
Conversion to is failed